eISSN: 1897-4317
ISSN: 1895-5770
Gastroenterology Review/Przegląd Gastroenterologiczny
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank
4/2007
vol. 2
 
Share:
Share:
more
 
 
abstract:

Review paper
The role of growth factors in pathogenesis of pancreatic cancer. Part II: Transforming growth factor beta (TGF- β), fibroblast growth factor (FGF), nerve growth factor (NGF)

Marek Olakowski

Przegląd Gastroenterologiczny 2007; 2 (4): 175–180
Online publish date: 2007/08/30
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Transforming growth factor beta (TGF- β) belongs to the family of dimeric polypeptide growth factors. It regulates various cellular processes through binding to three types of receptors. Studies with cell lines have shown that TGF- β1 may be one of the factors responsible for liver metastases, which contributes to local tumour progression and stimulates desmoplastic reaction in tumours. In clinical studies establishing the usefulness of TGF- β measurements in patients with pancreatic cancer various results have been demonstrated. Fibroblast growth factors (FGFs) induce a biological reaction through activation of tyrosine kinase receptors. In clinical studies a correlation between overexpression of FGFs in pancreatic cancer cells and the stage of tumour and survival has been shown. Nerve growth factor (NGF) is a member of the neurotrophin family. It binds to two types of receptor having tyrosine kinase activity. High expression of NGF receptors is more frequently observed in the case of cancer infiltration of perineural spaces.
keywords:

pancreatic cancer, transforming growth factor β, fibroblast growth factor, nerve growth factor

Quick links
© 2022 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.